Autoimmune Disease Diagnostics Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)

Autoimmune Disease Diagnostics Market – Report Overview

Pacific Business Consulting’s “Autoimmune Disease Diagnostics Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)” report offers a comprehensive understanding of Autoimmune Disease Diagnostics market, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Ten Major Markets (10MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, China, Australia, and India.

The global Autoimmune Disease Diagnostics market, valued at US$ 3.7 Billion in 2022, is anticipated to surpass US$ 5.0 Billion by 2030, exhibiting a Compound Annual Growth Rate (CAGR) exceeding 5.0% between 2023 and 2030.

Autoimmune diseases involve the body’s abnormal immune response, resulting in the production of antibodies that attack its own cells and tissues, leading to the deterioration and destruction of healthy tissues. With nearly 80 types of autoimmune diseases worldwide, including systemic lupus erythematosus and rheumatoid arthritis, their prevalence is substantial. According to estimates by the American Autoimmune Related Diseases Association (AARDA), up to 50 million Americans are affected by autoimmune diseases, with 75% of them being females. Diagnostic tests for autoimmune diseases include autoantibody tests, antinuclear antibody tests, complete blood count, C-reactive protein tests, and erythrocyte sedimentation rate tests.

The global autoimmune disease diagnostics market is driven by advancements in laboratory techniques and automation, increased public awareness of autoimmune disorders, growing partnerships between physicians and clinical laboratories, and a rise in the incidence of diseases such as rheumatoid arthritis, Graves disease, and Hashimoto’s thyroid disease. Challenges such as a high frequency of false-positive results and slow turnaround times for diagnostic test results restrain market growth. However, opportunities for growth are presented by rapid technological advancements, the development of emerging markets, and favorable government initiatives.

The prevalence of autoimmune disorders is on the rise globally. For instance, the number of people suffering from multiple sclerosis increased from 2.3 million in 2013 to 2.8 billion in 2020, according to data from the Multiple Sclerosis International Federation. Additionally, the World Health Organization (WHO) reported that around 18 million individuals worldwide suffered from rheumatoid arthritis in 2019. With the rising prevalence of autoimmune disorders, there is a growing need for the diagnosis of these conditions, contributing to the positive growth of the autoimmune disease diagnostics market.

Growing public awareness about early disease detection is another driver for the autoimmune disease diagnostics market. Awareness campaigns, such as Autoimmune Disease Awareness Month, play a critical role in educating the public and increasing the demand for early diagnosis.

However, challenges such as the high cost of diagnosing autoimmune diseases, long turnaround times, and the need for multiple tests may limit market growth. Slow turnaround times associated with conventional diagnostic techniques and a lack of standardized tests for over 80 disease types encourage laboratories to move toward automation.

Favorable government initiatives, including the efforts of organizations like the Autoimmunity Centers of Excellence, Cooperative Study Group for Autoimmune Disease Prevention, and North American Rheumatoid Arthritis Consortium, contribute positively to market dynamics by educating patients and healthcare professionals about proper diagnosis and treatment.

Key players in the Autoimmune Disease Diagnostics segment, including Thermofisher Scientific, Werfen, Bio-Rad Laboratories, Exagen Inc., Grifols, S.A, Medical & Biological Laboratories Co. Ltd, RSR Limited, Beckman Coulter, Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Quest Diagnostics, Hemagen Diagnostics, Inc., Trinity Biotech, and Biomerieux SA, are expected to shape the future landscape of autoimmune disease diagnostics technologies through ongoing innovation.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Autoimmune Disease Diagnostics market. It also delves into the analysis of present and prospective market competition within the global Autoimmune Disease Diagnostics market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

• Develop your business strategies by gaining insights into the trends that shape and drive the Autoimmune Disease Diagnostics market across the 10MM (Ten Major Markets).
• Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 10MM Autoimmune Disease Diagnostics market.
• Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
• Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

1. Executive Summary: Autoimmune Disease Diagnostics
   • Global Market Outlook: Autoimmune Disease Diagnostics
2. Competitive Intelligence Analysis: Autoimmune Disease Diagnostics
3. Therapeutic Sector SWOT
4. Technology Roadmap Analysis: Autoimmune Disease Diagnostics
5. Market Background
   • Drivers
   • Restraints
   • Opportunity
   • Key Market Trends
   • Key Unmet Needs
6. Key Marketed Products Profile – Major Approved Products: Autoimmune Disease Diagnostics
   • Product Profile
   • Safety and Efficacy
7. Regulatory Landscape
8. Autoimmune Disease Diagnostics: Ten Major Market (10MM) – Market Analysis, By Disease Type
   • Localized Autoimmune Disease
   • Systemic Autoimmune Disease
9. Autoimmune Disease Diagnostics: Ten Major Market (10MM) – Market Analysis, By Test Type
   • Antinuclear Antibody Test
   • C-reactive Protein
   • Comprehensive Metabolic Panel
   • Autoantibody Test
   • Others
10. Autoimmune Disease Diagnostics: Ten Major Market (10MM) – Market Analysis, By End User
    • Hospitals & Clinics
    • Diagnostic Centers
    • Other End Users
11. Autoimmune Disease Diagnostics: Ten Major Market (10MM) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Disease Type
      • By Test Type
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Disease Type
      • By Test Type
      • By End User

12. S. Autoimmune Disease Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Disease Type
      • By Test Type
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Disease Type
      • By Test Type
      • By End User

13. K. Autoimmune Disease Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Disease Type
      • By Test Type
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Disease Type
      • By Test Type
      • By End User

14. Germany Autoimmune Disease Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Disease Type
      • By Test Type
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Disease Type
      • By Test Type
      • By End User

15. France Autoimmune Disease Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Disease Type
      • By Test Type
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Disease Type
      • By Test Type
      • By End User

16. Italy Autoimmune Disease Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Disease Type
      • By Test Type
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Disease Type
      • By Test Type
      • By End User

17. Spain Autoimmune Disease Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Disease Type
      • By Test Type
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Disease Type
      • By Test Type
      • By End User

18. Japan Autoimmune Disease Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Disease Type
      • By Test Type
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Disease Type
      • By Test Type
      • By End User

19. China Autoimmune Disease Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Disease Type
      • By Test Type
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Disease Type
      • By Test Type
      • By End User

20. Australia Autoimmune Disease Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Disease Type
      • By Test Type
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Disease Type
      • By Test Type
      • By End User

21. India Autoimmune Disease Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Disease Type
      • By Test Type
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Disease Type
      • By Test Type
      • By End User

22. Competitive Landscape
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

23. Assumptions and Acronyms Used
24. Research Methodology
    • Secondary Research
    • Primary Research
    • Data Triangulation
25. Geographic Scope
    • The U.S., The U.K., Germany, France, Italy, Spain, Japan, China, Australia, and India
26. Copyrights and Disclaimer